- Patients
- Clinical Research
- Find a clinical trial
- AEMD Aethlon 2022-06
Basket - Other
AEMD Aethlon 2022-06
Safety, Feasibility, and Dose-Finding Study of Aethlon Hemopurifier in Patients with Solid Tumours who have stable or progressive disease during Pembrolizumab or Nivolumab Monotherapy.
Trial overview
Medical Oncology
Basket - Other
Basket
I
Registration number: ACTRN12624000732583
North Shore
North Shore Health Hub, Tower A, Level 1, 7 Westbourne St, St Leonards, NSW, 2065, Australia
Medical Oncologist
Prof. Stephen Clarke
OAM MBBS MD PhD FRACP FAChPM FAHMS
North Shore

Clinical trials enquiries
Disclaimer:
This website is provided for information purposes only. Nothing on this website is intended to be used as medical advice, or to diagnose, treat, cure or prevent any disease. It should not be used as a substitute for your own health professional's advice. Any medical procedure or treatment carries risks. Before proceeding with treatment, you should discuss the risks and benefits of the treatment with an appropriately qualified health practitioner. Individual treatment outcomes and experiences will vary.